Reaction Biology, a provider of drug discovery services, has expanded its Executive Leadership team with the appointments of Alan Findlater to the position of chief commercial officer (CCO) and Emily Doyle to the position of chief people officer (CPO).   Findlater and Doyle will also serve as members of the Executive Committee, effective immediately. These new appointments strengthen Reaction’s commercial and human resources functional areas.   “On behalf of the Executive Committee, we are i...